Skip to content

Zenect Wealth

Stock Research
  • HOME
  • ABOUT
  • CONTACT
  • GET YOUR FREE REPORT

Zenect Wealth

Stock Research
  • HOME
  • ABOUT
  • CONTACT
  • GET YOUR FREE REPORT

3 Tech Stocks With The Big Mo

  • by davidgoldstein
  • February 24, 2021February 24, 2021

“These are three top stocks for investors with plenty of risk tolerance to consider for aggressive growth portfolios,” says the author of today’s article of… 

CLICK HERE »3 Tech Stocks With The Big Mo

What’s To Love About Trading Options?

  • by davidgoldstein
  • February 23, 2021February 23, 2021

What’s to love about trading options? Quite a bit! From reducing risk, to providing the flexibility to react to market volatility, to achieving consistent returns… 

CLICK HERE »What’s To Love About Trading Options?

These Recent Insider Purchases Could Be Strong Signals To Potential Investors

  • by davidgoldstein
  • February 15, 2021February 16, 2021

When it comes to insider buying, the author of today’s article notes that “Conventional wisdom says that insiders and 10% owners really only buy shares… 

CLICK HERE »These Recent Insider Purchases Could Be Strong Signals To Potential Investors

Hijacking The Immune System Creates A Huge Opportunity For These Biotech Stocks

  • by davidgoldstein
  • February 13, 2021February 16, 2021

A huge opportunity exists for a group of biotech stocks seeking to “hijack the immune system” with bispecific antibodies. Just what are bispecific antibodies –… 

CLICK HERE »Hijacking The Immune System Creates A Huge Opportunity For These Biotech Stocks

With A Potential Blockbuster Alzheimer’s Drug, Is This Ten-Bagger Stock Still A Buy?

  • by davidgoldstein
  • February 11, 2021February 16, 2021

With a potential blockbuster drug in its pipeline that would also be the first new therapy for Alzheimer’s disease in decades, the stock featured in… 

CLICK HERE »With A Potential Blockbuster Alzheimer’s Drug, Is This Ten-Bagger Stock Still A Buy?

Feeling Bullish? These May Be “A Perfect Bet” Right Now For Outsized Returns

  • by davidgoldstein
  • February 7, 2021February 16, 2021

If stronger-than-expected fourth-quarter earnings, the prospect of massive government stimulus, and accelerating vaccine distribution has you feeling bullish, a perfect bet right now may be… 

CLICK HERE »Feeling Bullish? These May Be “A Perfect Bet” Right Now For Outsized Returns

5 Penny Stocks With Lots Of Hype – And Red Flags

  • by davidgoldstein
  • February 3, 2021February 16, 2021

“The allure of penny stocks lies in their potential to deliver massive gains in a short period of time. But in exchange for that opportunity,… 

CLICK HERE »5 Penny Stocks With Lots Of Hype – And Red Flags

These Biotech Stocks Could Get “Let Out Of The Cage” This Year

  • by davidgoldstein
  • February 1, 2021February 16, 2021

“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than… 

CLICK HERE »These Biotech Stocks Could Get “Let Out Of The Cage” This Year

With A Potential Solution To One Of The Biggest COVID Vaccine Problems, Could This Stock Be The Next Moderna?

  • by davidgoldstein
  • January 25, 2021February 16, 2021

This previously little-known immunotherapy stock recently saw its shares soar nearly 249% — and its market value surge from $300 million to more than $1… 

CLICK HERE »With A Potential Solution To One Of The Biggest COVID Vaccine Problems, Could This Stock Be The Next Moderna?

These Unicorns Are Growing The Fastest, Making Them Potential Future Investments

  • by davidgoldstein
  • January 21, 2021February 16, 2021

When it comes to unicorns – privately held startup companies valued at $1 billion or more – the author of today’s article remarks that the… 

CLICK HERE »These Unicorns Are Growing The Fastest, Making Them Potential Future Investments
  • 1
  • 2
  • 3
  • …
  • 151
  • Next »

Download Now!

Zenect Wealth

  • 3 Tech Stocks With The Big Mo
  • What’s To Love About Trading Options?
  • These Recent Insider Purchases Could Be Strong Signals To Potential Investors
  • Hijacking The Immune System Creates A Huge Opportunity For These Biotech Stocks
  • With A Potential Blockbuster Alzheimer’s Drug, Is This Ten-Bagger Stock Still A Buy?

Zenect Wealth

  • About
  • Contact
  • Advertise
  • Write For Us

Categories

  • Annuities
  • Gold, Oil, and Energy
  • Healthcare
  • On the Radar Reports
  • Retirement Dividends
  • Special Investment Situations
  • Uncategorized
  • Undervalued Penny Stocks
  • Videos
  • Wealth and Investments
  • Zenect Wealth

Download This Free Report

  • Disclaimer
  • Privacy Policy
  • General Terms and Conditions of Use
Zenect Wealth - All Rights Reserved